Identifying Drug-Target Selectivity of Small-Molecule CRM1/XPO1 Inhibitors by CRISPR/Cas9 Genome Editing
Jasper E. Neggers(Rega Institute for Medical Research), Thomas Vercruysse(Rega Institute for Medical Research), Maarten Jacquemyn(Rega Institute for Medical Research), Els Vanstreels(Rega Institute for Medical Research), Erkan Baloglu(Karyopharm Therapeutics (United States)), Sharon Shacham(Karyopharm Therapeutics (United States)), Marsha Crochiere(Karyopharm Therapeutics (United States)), Yosef Landesman(Karyopharm Therapeutics (United States)), Dirk Daelemans(Rega Institute for Medical Research)
Cited by 135